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Abstract 
Background 
Neither the incidence of indications for childhood tonsillectomy nor the proportion of 
tonsillectomies that are evidence-based are known.  
Aim 
Determine the incidence of indications for tonsillectomy in UK children and the proportion of 
tonsillectomies meeting evidence-based criteria.  
Design & Setting 
A retrospective cohort study of electronic medical records of children aged 0-15 years 
registered with 739 UK general practices contributing to a research database. 
Method 
Children with recorded indications for tonsillectomy were identified from electronic medical 
records. Evidence-based indications included documented sore throats of sufficient frequency 
and severity (Paradise criteria); aphthous stomatitis, pharyngitis and cervical adenitis 
syndrome (PFAPA); or tonsillar tumour. Other indications were considered non-evidence-
based. The numbers of children subsequently undergoing tonsillectomy were then identified. 
Among children who had undergone tonsillectomy the numbers with evidence-based and 
non-evidence-based indications for surgery were determined.  
Results 
We included 1,630,807 children, followed up for 7,200,159 person years between 2005 and 
2016. Incidence of evidence-based indications for tonsillectomy was 4.2 per 1000 person 
years: 13.6% (2,144/15,760) underwent tonsillectomy. Incidence of childhood tonsillectomy 
was 2.5 per 1000 person years: 11.7% (2,144/18,281) had evidence-based indications, almost 
all with Paradise criteria. The proportion of evidence-based tonsillectomies was unchanged 
over 12 years. Most childhood tonsillectomies followed non-evidence-based indications: 5 to 
6 sore throats (12.4%) or 2 to 4 sore throats (44.6%) in one year; sleep disordered breathing 
(12.3%) or obstructive sleep apnoea (3.9%).  
3 
 
Conclusion 
In the UK, few children with evidence-based indications undergo tonsillectomy and 32,500 
children annually undergo tonsillectomies from which they are unlikely to benefit.  
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How this fits in 
Evidence suggests tonsillectomy is effective in children with frequent, documented sore 
throats but not in less severely affected children and there is insufficient evidence to 
recommend its use for breathing difficulties.  
We found that each year between 2005 and 2016, about 4 in 1000 UK children had sufficient 
sore throats to meet evidence-based criteria for tonsillectomy but only about one in seven 
ever had the operation. This suggests tonsillectomy is far from essential.  
Over the same time period 2 to 3 in 1000 children underwent tonsillectomy each year of 
whom one in eight of these met evidence-based criteria, amounting to about 32,500 
unnecessary tonsillectomies annually at a cost of £36.9 million.  
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Introduction 
Tonsillectomy is the most common surgical procedure in children. Tonsillectomy rates in 
Belgium, Finland and Norway are twice the UK rate, but in Spain, Italy and Poland rates are 
much lower.1 Childhood tonsillectomy rates in the USA are three times higher than 
England,2,3 rates vary four-fold within New England and seven-fold within England (UK).4,5 
These variations are hard to explain in terms of need. The National Health Service (NHS) 
carried out approximately 37,000 childhood tonsillectomies from April 2016 to March 2017 
at a cost of £42.0 million.2,6 
Complications of tonsillectomy are more common than with other common childhood 
surgical procedures; 2.7% of children are readmitted within 30 days and 12.4% present to 
emergency departments often as a result of haemorrhage.7 Deaths occur occasionally.8 
Tonsillectomy may have long-term effects on the frequency of respiratory, infectious and 
allergic conditions.9 
Recurrent or chronic sore throat is the most common indication for tonsillectomy in the 
UK.10 Evidence indicates tonsillectomy results in modest, short term reductions in recurrent 
sore throats in severely affected children (aged 3 to 15 years) but is not worthwhile in less 
severely affected children.11,12,13 UK and US evidence-based guidelines therefore suggest 
offering tonsillectomy for children with ≥7 documented sore throats in a year; ≥5 yearly in 
two successive years; or ≥3 three yearly in three successive years: the Paradise criteria.2,14,15 
Sore throats should be characterised by at least one of the following: lymphadenopathy, 
tonsillar pus, fever, or evidence of Streptococcal infection. As undocumented sore throats 
have a more benign prognosis, eligibility requires documentation.16 The evidence base has 
not fundamentally changed since 2002.17,18 Tonsillectomy may also be carried out for 
tonsillar tumour. It may be effective in aphthous stomatitis, pharyngitis and cervical adenitis 
syndrome (PFAPA).19  
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Other potential indications for tonsillectomy lack convincing evidence. Only uncontrolled 
studies have evaluated tonsillectomy for recurrent peritonsillar abscess.20 
Adenotonsillectomy results in short term improvements in quality of life in children aged 5 to 
9 years with polysomnography-confirmed obstructive sleep apnoea.21 However its long-term 
value is debatable, tonsillectomy is unevaluated for snoring and of limited effectiveness for 
sleep apnoea unconfirmed by polysomnography.13 Trials of tonsillectomy for sleep apnoea 
are ongoing.22,23,24 Only very small non-randomized studies have evaluated tonsillectomy for 
guttate or chronic plaque psoriasis in children.25 Randomized controlled trial evidence does 
not show tonsillectomy affects clinical remission of glomerulonephritis.26  
No previous population wide study has described the epidemiology of potential indications 
for tonsillectomy or how many of those with different potential indications undergo 
tonsillectomy. This analysis therefore has three aims: to describe the incidence of potential 
indications for tonsillectomy in children, to determine the proportion of children undergoing 
tonsillectomy who met evidence-based criteria and to investigate if there have been changes 
in the potential indications over time. We hypothesize a mismatch between the evidence base 
and tonsillectomies performed: 1) most tonsillectomies are undertaken in children who are 
not eligible; 2) many eligible children do not undergo tonsillectomy.   
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Methods 
Data Source and Study Cohort 
This is a retrospective open cohort study of children aged 0 to 15 years, registered with a 
general practice contributing to The Health Improvement Network (THIN). THIN is a 
database of anonymized patient records from over 700 UK general practices. It contains 
information on diagnoses, symptoms, referrals to secondary care, tests and treatments in 
primary care.27 It is broadly generalizable to the UK population in terms of demographics and 
medical condition prevalence.28,29  
The researchers had complete access to the full THIN database. Data were only included after 
the date of practice acceptable mortality reporting. This is the date after which patient 
deregistrations in each practice were recorded consistently, ensuring that the denominator, the 
registered population, was accurate.30 Children were eligible for inclusion from birth, or if 
not registered with a THIN practice from birth, then registered for at least three years prior to 
entry. This allows sufficient time to meet the evidence-based criteria for tonsillectomy. The 
earliest year of entry to the cohort was set to 2000.  
Children who had a tonsillectomy prior to entry in the cohort were excluded. Patients were 
followed up until the earliest of the following dates: age 16 years; death; leaving the practice 
(deregistration); last data extraction from the practice; or tonsillectomy.  
Exposures 
Potential indications for tonsillectomy were identified from clinical coded consultations for 
sore throat episodes, tonsillar neoplasia, PFAPA, peritonsillar abscess, sleep apnoea, other 
sleep disordered breathing, glomerulonephritis and guttate and chronic plaque psoriasis. As it 
is difficult to distinguish new sore throat episodes from ongoing episodes a pragmatic 
decision was taken to consider any consultation for sore throat (including pharyngitis, 
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tonsillitis, throat infection, sore throat symptoms) at least 14 days after the previous 
consultation as a new episode. Code lists are provided in supplementary appendices. Patients 
were categorized according to potential indications for tonsillectomy. 
In initial analysis we were unable to identify any potential indications for some patients who 
underwent tonsillectomy. This may have occurred because some consultations for sore 
throats were recorded using a less specific code such as another upper respiratory tract 
infection. We therefore broadened the definition of a sore throat consultation to include any 
consultations with a clinical code for upper respiratory tract infection or otitis media. We also 
conducted a sensitivity analysis, including in our counts of sore throat episodes any 
consultations where no code for upper respiratory tract infection was used but an oral 
antibiotic commonly used for sore throat (Penicillin V, Erythromycin or Clarithromycin) was 
prescribed.  
Incidence of potential indications for tonsillectomy 
To calculate the annual incidence of evidence-based indications for tonsillectomy we 
determined the number of children who met at least one evidence-based indication in any 
given year. Evidence-based indications included: tonsillar neoplasia; PFAPA; ≥7 sore throat 
episodes sore throats in the preceding year, ≥5 yearly in the two preceding years, or ≥3 yearly 
in the three preceding years (Paradise criteria for sore throats).14 
Proportion of tonsillectomies that are evidence-based 
Indications for tonsillectomy were ranked to determine the strongest indication (based first on 
strength of evidence then on clinical consensus reflected in current practice) and this was 
taken to be the true indication for tonsillectomy. Tonsillar neoplasia was considered the 
strongest indication for tonsillectomy, followed by: PFAPA and Paradise criteria for sore 
throats. These indications for tonsillectomy were considered to be evidence-based. The next 
strongest indications were considered sequentially to be obstructive sleep apnoea, other sleep 
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disordered breathing, peritonsillar abscess; ≥5 sore throat episodes recoded in the preceding 
year but not meeting the Paradise criteria; recurrent sore throat episodes accompanied by 
guttate or chronic plaque psoriasis, or glomerulonephritis; three to four, two and one sore 
throat episodes in the preceding year (the weakest indication).  
We initially considered tonsillectomy to be indicated for one year after the patient consulted 
with the indication. In each child who underwent tonsillectomy we also identified the 
strongest indication at any time prior to surgery based on available patient records. This could 
overestimate the number of tonsillectomies considered evidence-based if an older child had 
tonsillectomy for an indication that was not evidence-based but they had a prior history of 
stronger indications.  
Changes to the analysis 
In initial analysis, when we considered tonsillectomy to be indicated only one year after the 
onset of the indication (e.g. up to one year after the seventh sore throat), no apparent 
indication could be identified for 19.1% (4,406/23,116) of tonsillectomies between 2000 and 
2016. When we considered tonsillectomy to be indicated at any time after the indication, the 
proportion of tonsillectomies with no indication fell to 5.4% (1,246/23,116). Over 10% of 
tonsillectomies had no identifiable indication in the early years of the cohort (10.2% in 2000 
and 2001), but was lower from 2005 onwards. The primary analysis therefore allowed 
indications at any time prior to tonsillectomy and was confined to 2005 to 2016. 
Outcome 
The main outcome of interest was tonsillectomy or adenotonsillectomy. 
Statistical Analysis 
Incidence of potential indications for tonsillectomy 
The annual incidence of potential indications for tonsillectomy was calculated as the number 
of children who met at least one potential indication for tonsillectomy in each year per person 
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year of follow up. We then determined the annual incidence of evidence-based indications for 
tonsillectomy to estimate potential annual need for tonsillectomy. 
The strongest indication for tonsillectomy was determined for each child in the cohort and the 
proportion of children undergoing tonsillectomy after this strongest indication was calculated.  
Incidence of tonsillectomy and indications for tonsillectomies undertaken 
The annual incidence of tonsillectomy was estimated as the number of children undergoing 
the procedure per person year of follow up. Incidence estimates were directly standardized to 
the 2015 UK population31 to enable comparisons over time: 95% confidence intervals (CIs) 
were calculated using Poisson approximation.  
For each tonsillectomy the strongest potential indication at any time prior to surgery was 
identified and the proportion of tonsillectomies attributed to each indication determined. 
Potential indications were then categorized as evidence-based or not evidence-based and the 
proportion of evidence-based tonsillectomies calculated. Data were analysed using Stata 
version 14.32 
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Results 
During 2005-2016 the cohort included 739 general practices, 1,630,807 children aged 0-15 
years, 7,200,159 person years of follow up and 18,281 tonsillectomies (Table 1). 
Annual incidence of indications for tonsillectomy 
Sore throat consultations declined from 2005 to 2016. Incidence of sore throats meeting 
Paradise criteria (98.0% of evidence-based indications) was 28% lower in 2016 than 2005. 
(Table 1). Similarly consultations for 5 to 6 sore throats in a year fell by 27%; for 3 to 4 
recurrent sore throats fell by 22%; for 2 to 3 sore throats by 19%; by 13% for a single sore 
throat. Consultations for peritonsillar abscess also fell by 39%. By contrast consultations for 
sleep apnoea rose 48% from 2005 to 2016 and those for sleep disordered breathing rose 2%. 
Between 2005 and 2016 the average annual incidence of meeting at least one evidence-based 
indication for tonsillectomy in children was 4.2 per 1,000 person years. A much larger 
number of children consulted with other potential indications for tonsillectomy which did not 
meet evidence-based criteria, particularly with one, two, or three to four sore throats in a 
year. (Table 2)  
Frequency of tonsillectomy in children with indications 
Few children 13.6% (2,144/15,760) with an evidence-based indication underwent 
tonsillectomy. Likelihood of undergoing tonsillectomy increased with frequency of sore 
throat consultations in a single year: 3.2% (5,503/170,687) with 3 to 4 sore throats, 8.9% 
(2,266/25,420) with 5 to 6 annual sore throats and 13.9% (2,129/15,320) of those meeting 
Paradise criteria. The vast majority of children consulting with recurrent sore throats did not 
undergo tonsillectomy however the small proportion that did accounted for most 
tonsillectomies. (Figure 1) The indications most likely to be followed by tonsillectomy were 
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sleep apnoea, 22.2% (706/3,185), followed by peritonsillar abscess 14.8% (100/675) and 
sleep disordered breathing 14.8% (2,246/15,205). (Table 2)  
Annual Incidence of tonsillectomy 
The crude annual incidence of tonsillectomy was 2.5 per 1000 person years. It followed a 
broadly similar pattern to the incidence of indications, declining from 2005 to 2011 and then 
remaining relatively stable (Table 1). Age-adjustment had little effect on trends or rates. 
Annual English hospital-reported tonsillectomy rates showed the same temporal pattern as 
our primary care data.  
Indications for tonsillectomies undertaken from 2005 to 2016 
From 2005 to 2016 11.7% (2,144/18,281) of tonsillectomies had evidence-based indications, 
99.3% of these met the Paradise criteria. Tonsillectomies without an evidence base were 
mainly for sore throats: five to six (12.4%), two to four (44.7%) or one (9.9%) within a single 
year. In addition, 3.9% were for sleep apnoea and 12.3% for other sleep disordered breathing. 
The proportion of tonsillectomies attributable to Paradise criteria, five or six annual sore 
throats or to other sleep disordered breathing changed little. The proportion attributable to 
obstructive sleep apnoea increased fourfold from 1.2% to 5.5%. (Figure 2)  
  
13 
 
Discussion 
Summary of findings 
About four in 1,000 children met evidence-based criteria for tonsillectomy annually between 
2005 and 2016. The vast majority had recurrent sore throat consultations meeting Paradise 
criteria. Fewer than one in seven underwent surgery.  
Two or three children in 1000 underwent tonsillectomy annually between 2005 and 2016. 
Fewer than one in eight had evidence-based indications. The proportion did not change over 
twelve years. In the UK 32,500 of the 37,000 childhood tonsillectomies in 2016 to 2017 were 
therefore unnecessary. Most (54.5%) tonsillectomies were carried out on the very large 
numbers of children who consulted with one to four sore throats in a year but the vast 
majority of these children do not undergo tonsillectomy. The mismatch between children 
meeting evidence-based criteria and those undergoing tonsillectomy is shown in Figure 3. 
Strengths and limitations 
Our findings are obtained from a very large dataset reflecting current UK clinical practice 
over 12 years and captures both free NHS and private tonsillectomies. Our tonsillectomy 
rates correlated closely with childhood tonsillectomy rates reported in England Hospital 
Episode Statistics (r = 0.896).  
We identified likely indications for 95.2% of tonsillectomies from clinically coded 
consultations. Consultations in primary care are 15 times more common than in emergency 
departments and upper respiratory infections is uncommon in the latter therefore primary care 
records will miss few relevant consultations.33,34  
Paradise criteria require specific documentation of sore throats and their clinical features. Our 
broad (sensitive) definition of a sore throat, counting any upper respiratory tract infection 
consultation as a sore throat episode, may overestimate the frequency of evidence-based 
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indications. In sensitivity analyses we investigated the effect of using an even broader (more 
sensitive) include any consultation without a clinical code where antibiotics consistent with a 
sore throat episode were prescribed (Penicillin V, Erythromycin or Clarithromycin). This 
increased the number of evidence-based tonsillectomies to 17.5%. We then used a narrower 
(more specific) definition of a sore throat, including only those clinically coded as sore throat 
episodes. This reduced the proportion of evidence-based tonsillectomies to 4.4%, reduced the 
proportion of tonsillectomies attributable to sore throat to 70.9% and increased the proportion 
without an identifiable indication to 11.1%. Under all scenarios only a minority of 
tonsillectomies were evidence based and even with the narrowest definition of sore throat, 
only a minority (32.0%) of children meeting Paradise criteria underwent tonsillectomy.  
For sore throat related indications we initially intended to consider tonsillectomy to be 
indicated for only one year after the patient last consulted for the indication. But median time 
from indication to tonsillectomy was 356 days and applying a one year time limit for 
indications meant we were unable to identify any indications for an additional 13% of 
tonsillectomies. We therefore identified the best ever indication rather than indications within 
the year prior to tonsillectomy, this may overestimate the frequency of evidence-based 
indications. 
Some may consider there is sufficient evidence to support tonsillectomy for other indications. 
Children affected by recurrent otitis media may benefit modestly from adenotonsillectomy 
although it is unclear if tonsillectomy adds to the benefits of adenoidectomy.35 Tonsillectomy 
may be beneficial for sleep apnoea confirmed by polysomnography in five to nine year olds, 
for peritonsillar abscess or for psoriasis.19,20,25 Others conclude the evidence does not support 
tonsillectomy in PFAPA.36 But a combination of evidence-based indications, or breathing 
related indications or peritonsillar abscess accounts for only 28.4% of tonsillectomies. 
Furthermore, most children with any of these indications do not undergo tonsillectomy. Using 
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a broader definition of eligibility for treatment increases the proportion of tonsillectomies that 
can be considered indicated, but decreases the proportion of eligible children who undergo 
surgery.  
Comparison to literature 
This is the first ever study to estimate the incidence of evidence-based indications for 
tonsillectomy in children and the proportion of affected children who undergo the procedure. 
It is the first study to comprehensively estimate the proportion of tonsillectomies that are 
evidence-based. A study in 23, self-selected, UK general practices found a quarter of 237 
tonsillectomies in the late 1990s met evidence-based criteria.37 A larger analysis suggested 
<1% of tonsillectomy patients in 2008 met Paradise criteria.38 However this study probably 
underestimated eligibility as it required sore throats to be precisely coded in general practice 
records. 
Although others report rising hospital admissions for peritonsillar abscess, we found primary 
care consultations for peritonsillar abscess and for recurrent sore throat consistently declined 
over the same period.39 This suggests a changing pattern of presentation rather than an 
increase in incidence. 
We found UK tonsillectomy rates changed little from 2005 to 2016, with a slight decline in 
the years to 2011, followed by a modest increase. By comparison, in Germany childhood 
tonsillectomy rates decreased by 17.3% from 2010 to 2013 but rates remain twice those in the 
UK.40 We found an increasing propensity for sleep apnoea consultations to result in 
tonsillectomy: sleep apnoea consultations increased by about half but tonsillectomies for 
obstructive sleep apnoea increased four-fold. Overall our attribution of indications for 
childhood tonsillectomy – 78.5% sore throat, 16.2% obstructive symptoms and 0.5% 
peritonsillar abscess – is comparable to a national UK audit – 83.3%, 14.7% and 0.4% 
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respectively.10 Fewer tonsillectomies could be attributed to sleep apnoea than the 25% 
suggested by UK professional bodies41 or the two thirds reported from the USA.42,43  
We found guideline discordant (overtreatment alongside possible under treatment) clinical 
management of recurrent sore throat in the UK to be stable over many years. Overtreatment is 
an increasingly recognized phenomenon.44,45 Guideline discordant clinical management has 
been observed in relation to both statins and depression and in the USA has increased in 
relation to back pain and headache.46,47,48,49  
Implications for practice and research 
We await the results of current trials of tonsillectomy for obstructive sleep disordered 
breathing.22,23,24 High quality randomized controlled trials are also needed to evaluate 
tonsillectomy for peritonsillar abscess, guttate and chronic plaque psoriasis. The frequency of 
indications for tonsillectomy and evidence-based tonsillectomies should be investigated in 
countries with higher and lower tonsillectomy rates than the UK.  
Our findings have some practical implications for UK clinical practice. Because they are 
undertaken on children who do not benefit, most tonsillectomies may cause more harm than 
good. This is ethically dubious and cannot be a good use of resources. Most children meeting 
evidence based criteria do not undergo tonsillectomy, therefore it cannot be considered a 
necessity. We should already inform parents of the likely effectiveness of tonsillectomy. We 
can now also inform them that most children with either recurrent sore throats or sleep 
apnoea do not undergo tonsillectomy.  
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 Tables and figures 
Table 1: Characteristics of the study population from 2005 to 2016 
 
Year 
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 
Number of practices 556 577 603 643 654 648 649 662 644 609 545 451 
Number of children 590,724 622,505 651,308 694,342 720,955 724,153 730,833 753,756 746,245 705,936 643,183 530,462 
Person years 524,613 560,254 586,007 614,620 646,898 649,855 661,183 674,169 662,071 617,813 544,197 458,480 
Mean age (years) 7.9 7.8 7.8 7.8 7.8 7.8 7.8 7.8 7.8 7.8 7.8 7.8 
No. of males 307,925 323,551 337,702 358,948 371,608 372,224 374,953 386,071 381,930 361,168 328,770 271,135 
(%) (52.1) (52.0) (51.9) (51.7) (51.5) (51.4) (51.3) (51.2) (51.2) (51.2) (51.1) (51.1) 
Townsend quintile † (%)             
Least deprived 1 24.4 24.8 24.8 24.2 24.1 24.0 23.4 22.6 21.9 21.3 20.5 18.6 
2 19.2 19.2 19.2 19.5 19.6 19.5 19.4 18.9 18.5 18.4 18.3 17.4 
3 19.2 19.0 19.1 19.4 19.6 19.6 19.7 19.6 19.5 19.7 19.4 19.0 
4 17.2 17.1 17.0 17.0 17.2 17.2 17.3 17.6 17.8 17.7 17.8 17.4 
Most deprived 5 12.6 12.3 12.5 12.5 12.6 12.6 12.6 13.0 13.1 13.2 13.4 13.9 
Not known 7.4 7.6 7.4 7.5 6.9 7.3 7.7 8.4 9.1 9.8 10.7 13.8 
No. of children with Evidence  
Based Indications* 2,359 2,483 2,587 2,689 2,699 2,722 2,768 2,864 2,948 2,692 2,155 1,494 
(per 1,000 Person Years) (4.5) (4.4) (4.4) (4.4) (4.2) (4.2) (4.2) (4.2) (4.5) (4.4) (4.0) (3.3) 
No. of Tonsillectomies 1,555  1,551  1,648  1,620  1,599  1,564  1,468  1,581  1,698  1,598  1,275  1,124  
(per 1,000 Person Years) (3.0) (2.8) (2.8) (2.6) (2.5) (2.4) (2.2) (2.3) (2.6) (2.6) (2.3) (2.5) 
* A child who consults with an evidence-based indication can be eligible for tonsillectomy in more than one calendar year if the indication crossed the calendar year. The total number of 
children consulting with evidence based indications over 12 years is therefore smaller than the sum of the number for each year. † Townsend score is an area based measure of deprivation.
 
  
Table 2: Numbers of children with potential indications for tonsillectomy, annual 
incidence of potential indications and the proportions of these children undergoing 
tonsillectomy (2005 to 2016) 
Recorded indication for 
tonsillectomy* 
Number with 
this indication 
Proportion with 
this indication 
undergoing 
tonsillectomy 
(%) 
Proportion of all 
tonsillectomies 
attributable to 
this indication 
(%) 
Average annual 
incidence of 
this indication 
(per 100,000 
Person Years) 
Ev
id
en
ce
-b
as
ed
 Tonsillar tumour 5 0.0 0.0 0.2 
Aphthous stomatitis, 
pharyngitis and cervical 
adenitis syndrome 
(PFAPA) 
435 3.4 0.1 8.5 
Paradise criteria‡ 15,320 13.9 11.6 412.8 
N
on
 e
vi
de
nc
e-
ba
se
d 
Obstructive sleep apnoea 3,185 22.2 3.9 65.9 
Other sleep disordered 
breathing 15,205 14.8 12.3 369.9 
Peritonsillar abscess 675 14.8 0.5 14.9 
Recurrent sore throats: 5 
to 6 in one year† 25,420 8.9 12.4 840.4 
Recurrent sore throats: 2 
to 4 in one year with 
guttate or chronic plaque 
psoriasis† 
939 3.7 0.2 21.3 
Recurrent sore throats: 2 
to 4 in one year with 
glomerulonephritis† 
148 4.7 0.0 3.5 
Recurrent sore throats: 3 
to 4 in one year† 170,687 3.2 30.1 5,869.1 
Recurrent sore throats: 2 
in one year† 251,247 1.0 14.3 12,321.6 
Recurrent sore throats: 1 
in one year† 446,275 0.4 9.9 27,896.5 
No indication identified 701,266 0.1 4.7 n/a 
Total 1,630,807 1.1 100.0 n/a 
*If a child met criteria for several indications, the indication higher in the hierarchy would be counted. 
†Broad definition of sore throat: includes consultations for any upper respiratory tract infection or otitis media 
‡ Paradise criteria: Recurrent sore throats or upper respiratory tract infections: ≥7 a year; ≥5 yearly for two 
years; ≥3 yearly for three years 
 
 Figure 1: Numbers of children consulting for sore throats† and numbers undergoing 
tonsillectomy (2005 to 2016). 
 
†Broad definition of sore throat: includes consultations for any upper respiratory tract infection or otitis media 
* Paradise criteria: Recurrent sore throats or upper respiratory tract infections: ≥7 a year; ≥5 yearly for two 
years; ≥3 yearly for three years 
  
 
  
Figure 2: Percentages of tonsillectomies due to different indications 2005-2016 
 
* Broad definition of sore throat: includes consultations for any upper respiratory tract infection or otitis media 
†3-4 sore throats include children with guttate, chronic plaque psoriasis and glomerulonephritis with recurrent 
sore throats (these, however accounted only for 0.5% of all children in this group of recurrent sore throats who 
had tonsillectomy) 
Paradise criteria: Recurrent sore throats or upper respiratory tract infections: ≥7 a year; ≥5 yearly for two 
years; ≥3 yearly for three years 
‡ Evidence-based criteria include Paradise criteria, PFAPA and tonsillar tumour (the last two accounted for 
0.7% of all tonsillectomies meeting evidence-based criteria) 
  
 
 Figure 3: Relationship between number of children meeting evidence-based criteria 
(Paradise criteria, PFAPA or tonsillar tumour) for tonsillectomy and numbers of 
children undergoing tonsillectomy from to 2005-2016 
 
Appendices: Clinical code lists 
Appendix 1: Read code list for neoplastic growths of the tonsil 
Code Description 
B016.00 Malignant neoplasm of lingual tonsil 
B060.00 Malignant neoplasm of tonsil 
B060000 Malignant neoplasm of faucial tonsil 
B060100 Malignant neoplasm of palatine tonsil 
B060200 Malignant neoplasm of overlapping lesion of tonsil 
B060z00 Malignant neoplasm tonsil NOS 
B061.00 Malignant neoplasm of tonsillar fossa 
B062.00 Malignant neoplasm of tonsillar pillar 
B062300 Malignant neoplasm of palatopharyngeal arch 
B062z00 Malignant neoplasm of tonsillar fossa NOS 
B071100 Malignant neoplasm of pharyngeal tonsil 
B072000 Malignant neoplasm of pharyngeal recess 
B701300 Benign neoplasm of lingual tonsil 
B705.00 Benign neoplasm of tonsil 
B706000 Benign neoplasm of tonsillar fossa 
B706100 Benign neoplasm of anterior tonsillar pillar 
B706200 Benign neoplasm of posterior tonsillar pillar 
B706500 Benign neoplasm of oropharyngeal wall 
B707000 Benign neoplasm of nasopharyngeal roof 
B707100 Benign neoplasm of pharyngeal tonsil 
B707200 Benign neoplasm of pharyngeal recess 
B707300 Benign neoplasm of nasopharyngeal floor 
B708300 Benign neoplasm of posterior hypopharyngeal wall 
 
 Appendix 2: Read code list for PFAPA 
Code Description 
133E.00 Aphthous stomatitis 
A784.11 Aphthous fever 
J082100 Major aphthous ulceration 
J082200 Recurrent aphthous ulceration 
J082400 Aphthous stomatitis 
Appendix 3: Read code list for sore throat and other upper respiratory tract infections 
Code Description 
1C9..00 Sore throat symptom 
1C9..11 Throat soreness 
1C92.00 Has a sore throat 
1C93.00 Persistent sore throat 
1C9Z.00 Sore throat symptom NOS 
1CB..00 Throat symptom NOS 
1CB3.00 Throat pain 
1CB3.11 Pain in throat 
1CB5.00 Throat irritation 
1CBZ.00 Throat symptom NOS 
2DB6.00 O/E - follicular tonsillitis 
2DC2.00 O/E - granular pharyngitis 
2DC3.00 Inflamed throat 
A34..00 Streptococcal sore throat and scarlatina 
A340.00 Streptococcal sore throat 
A340000 Streptococcal angina 
A340200 Streptococcal pharyngitis 
A340300 Streptococcal tonsillitis 
A340z00 Streptococcal sore throat NOS 
A34z.00 Streptococcal sore throat with scarlatina NOS 
A383000 Fusobacterial necrotising tonsillitis 
A552.00 Postmeasles otitis media 
AA12.00 Vincent's pharyngitis 
AA1z.11 Vincent's laryngitis 
AA1z.12 Vincent's tonsillitis 
F510000 Acute otitis media with effusion 
F510011 Acute secretory otitis media 
F510100 Acute serous otitis media 
F510200 Acute mucoid otitis media 
F510300 Acute sanguinous otitis media 
F510400 Acute allergic serous otitis media 
F510500 Acute allergic mucoid otitis media 
F510600 Acute allergic sanguinous otitis media 
F511.00 Chronic otitis media with effusion, serous 
F511.11 Chronic secretory otitis media, serous 
 
 Code Description 
F511100 Serosanguinous chronic otitis media 
F511z00 Chronic serous otitis media NOS 
F512.00 Chronic otitis media with effusion, mucoid 
F512.12 Chronic secretory otitis media, mucoid 
F512100 Mucosanguinous chronic otitis media 
F512z00 Chronic mucoid otitis media NOS 
F513.00 Chronic otitis media with effusion, other 
F513000 Chronic allergic otitis media 
F513100 Chronic otitis media with effusion, purulent 
F513111 Chronic secretory otitis media, purulent 
F514000 Allergic otitis media NOS 
F514100 Serous otitis media NOS 
F514200 Catarrhal otitis media NOS 
F514300 Mucoid otitis media NOS 
F518.00 Chronic otitis media with effusion, unspecified 
F52..00 Suppurative and unspecified otitis media 
F520.00 Acute suppurative otitis media 
F520000 Acute suppurative otitis media tympanic membrane intact 
F520100 Acute suppurative otitis media tympanic membrane ruptured 
F520300 Acute suppurative otitis media due to disease EC 
F520z00 Acute suppurative otitis media NOS 
F521.00 Chronic suppurative otitis media, tubotympanic 
F522.00 Chronic suppurative otitis media, atticoantral 
F523.00 Chronic suppurative otitis media NOS 
F524.00 Purulent otitis media NOS 
F524000 Bilateral suppurative otitis media 
F525.00 Recurrent acute otitis media 
F526.00 Acute left otitis media 
F527.00 Acute right otitis media 
F528.00 Acute bilateral otitis media 
F52z.00 Otitis media NOS 
FyuP200 [X]Other chronic suppurative otitis media 
FyuP300 [X]Otitis media in bacterial diseases classified elsewhere 
FyuP400 [X]Otitis media in viral diseases classified elsewhere 
H00..00 Acute nasopharyngitis 
H00..11 Common cold 
H00..12 Coryza - acute 
H00..13 Febrile cold 
H00..14 Nasal catarrh - acute 
H00..15 Pyrexial cold 
H00..16 Rhinitis - acute 
H01..00 Acute sinusitis 
H01..11 Sinusitis 
 
 Code Description 
H010.00 Acute maxillary sinusitis 
H010.11 Antritis - acute 
H011.00 Acute frontal sinusitis 
H012.00 Acute ethmoidal sinusitis 
H013.00 Acute sphenoidal sinusitis 
H014.00 Acute rhinosinusitis 
H01y.00 Other acute sinusitis 
H01y000 Acute pansinusitis 
H01yz00 Other acute sinusitis NOS 
H01z.00 Acute sinusitis NOS 
H02..00 Acute pharyngitis 
H02..11 Sore throat NOS 
H02..12 Viral sore throat NOS 
H02..13 Throat infection - pharyngitis 
H020.00 Acute gangrenous pharyngitis 
H021.00 Acute phlegmonous pharyngitis 
H022.00 Acute ulcerative pharyngitis 
H023.00 Acute bacterial pharyngitis 
H023000 Acute pneumococcal pharyngitis 
H023100 Acute staphylococcal pharyngitis 
H023z00 Acute bacterial pharyngitis NOS 
H024.00 Acute viral pharyngitis 
H025.00 Allergic pharyngitis 
H02z.00 Acute pharyngitis NOS 
H03..00 Acute tonsillitis 
H03..11 Throat infection - tonsillitis 
H03..12 Tonsillitis 
H030.00 Acute erythematous tonsillitis 
H031.00 Acute follicular tonsillitis 
H032.00 Acute ulcerative tonsillitis 
H033.00 Acute catarrhal tonsillitis 
H034.00 Acute gangrenous tonsillitis 
H035.00 Acute bacterial tonsillitis 
H035000 Acute pneumococcal tonsillitis 
H035100 Acute staphylococcal tonsillitis 
H035z00 Acute bacterial tonsillitis NOS 
H036.00 Acute viral tonsillitis 
H037.00 Recurrent acute tonsillitis 
H03z.00 Acute tonsillitis NOS 
H04..00 Acute laryngitis and tracheitis 
H040.00 Acute laryngitis 
H040000 Acute oedematous laryngitis 
H040100 Acute ulcerative laryngitis 
 
 Code Description 
H040200 Acute catarrhal laryngitis 
H040300 Acute phlegmonous laryngitis 
H040400 Acute haemophilus influenzae laryngitis 
H040500 Acute pneumococcal laryngitis 
H040600 Acute suppurative laryngitis 
H040w00 Acute viral laryngitis unspecified 
H040x00 Acute bacterial laryngitis unspecified 
H040z00 Acute laryngitis NOS 
H041.00 Acute tracheitis 
H041000 Acute tracheitis without obstruction 
H041100 Acute tracheitis with obstruction 
H041z00 Acute tracheitis NOS 
H042.00 Acute laryngotracheitis 
H042.11 Laryngotracheitis 
H042000 Acute laryngotracheitis without obstruction 
H042100 Acute laryngotracheitis with obstruction 
H042z00 Acute laryngotracheitis NOS 
H043.00 Acute epiglottitis (non strep) 
H043.11 Viral epiglottitis 
H043000 Acute epiglottitis without obstruction 
H043100 Acute epiglottitis with obstruction 
H043200 Acute obstructive laryngitis 
H043211 Croup 
H043z00 Acute epiglottitis NOS 
H044.00 Croup 
H04z.00 Acute laryngitis and tracheitis NOS 
H05..00 Other acute upper respiratory infections 
H050.00 Acute laryngopharyngitis 
H051.00 Acute upper respiratory tract infection 
H052.00 Pharyngotracheitis 
H053.00 Tracheopharyngitis 
H054.00 Recurrent upper respiratory tract infection 
H055.00 Pharyngolaryngitis 
H05y.00 Other upper respiratory infections of multiple sites 
H05z.00 Upper respiratory infection NOS 
H05z.11 Upper respiratory tract infection NOS 
H05z.12 Viral upper respiratory tract infection NOS 
H12..00 Chronic pharyngitis and nasopharyngitis 
H121.00 Chronic pharyngitis 
H121.11 Sore throat - chronic 
H121000 Simple chronic pharyngitis 
H121100 Atrophic pharyngitis 
H121200 Granular pharyngitis 
 
 Code Description 
H121300 Hypertrophic pharyngitis 
H121400 Pharyngitis keratosa 
H121500 Pharyngitis sicca 
H121600 Chronic follicular pharyngitis 
H121z00 Chronic pharyngitis NOS 
H122.00 Chronic nasopharyngitis 
H12z.00 Chronic pharyngitis and nasopharyngitis NOS 
H13..00 Chronic sinusitis 
H13..11 Chronic rhinosinusitis 
H130.00 Chronic maxillary sinusitis 
H130.11 Antritis - chronic 
H130.12 Maxillary sinusitis 
H131.00 Chronic frontal sinusitis 
H131.11 Frontal sinusitis 
H132.00 Chronic ethmoidal sinusitis 
H133.00 Chronic sphenoidal sinusitis 
H134.00 Fistula of nasal sinus 
H135.00 Recurrent sinusitis 
H13y.00 Other chronic sinusitis 
H13y000 Chronic pansinusitis 
H13y100 Pansinusitis 
H13yz00 Other chronic sinusitis NOS 
H13z.00 Chronic sinusitis NOS 
H14..00 Chronic tonsil and adenoid disease 
H14..11 Adenoid disease - chronic 
H14..12 Tonsil disease - chronic 
H140.00 Chronic tonsillitis 
H140.11 Chronic adenoiditis 
H142.00 Adenoid vegetations 
H143.00 Chronic adenotonsillitis 
H14y.00 Other chronic diseases of tonsils and adenoids 
H14y000 Calculus of tonsil 
H14y011 Amygdalolith 
H14y012 Tonsillolith 
H14y100 Cicatrix of tonsil 
H14y200 Cicatrix of adenoid 
H14y300 Tonsillar tag 
H14y400 Tonsil ulcer 
H14y500 Caseous tonsillitis 
H14y600 Lingular tonsillitis 
H14y700 Cyst of tonsil 
H14y711 Tonsillar cyst 
H14yz00 Other chronic diseases of tonsils and adenoids NOS 
 
 Code Description 
H14z.00 Chronic tonsil and adenoid disease NOS 
H14z000 Chronic tonsil disease NOS 
H14z100 Chronic adenoid disease NOS 
H15..00 Peritonsillar abscess - quinsy 
H15..11 Quinsy 
H16..00 Chronic laryngitis and laryngotracheitis 
H160.00 Chronic laryngitis 
H160000 Chronic simple laryngitis 
H160100 Chronic catarrhal laryngitis 
H160200 Chronic hypertrophic laryngitis 
H160300 Chronic atrophic laryngitis 
H160400 Laryngitis sicca 
H160500 Congested larynx 
H160z00 Chronic laryngitis NOS 
H161.00 Chronic laryngotracheitis 
H16z.00 Chronic laryngitis NOS 
H1y..00 Other specified diseases of upper respiratory tract 
H1y2.00 Other pharyngeal disease NEC 
H1y2.11 Other nasopharyngeal disease NEC 
H1y2000 Pharyngeal disease unspecified 
H1y2200 Parapharyngeal abscess 
H1y2300 Retropharyngeal abscess 
H1y2600 Pharynx or nasopharynx abscess 
H1y2z00 Other pharyngeal disease NOS 
H1yz.00 Other upper respiratory tract diseases NOS 
H1yzz00 Other upper respiratory tract disease NOS 
H271000 Influenza with laryngitis 
H271100 Influenza with pharyngitis 
Hyu0.00 [X]Acute upper respiratory infections 
Hyu0000 [X]Other acute sinusitis 
Hyu0100 [X]Acute pharyngitis due to other specified organisms 
Hyu0200 [X]Acute tonsillitis due to other specified organisms 
Hyu0300 [X]Other acute upper respiratory infections/multiple sites 
Hyu2.00 [X]Other diseases of the upper respiratory tract 
Hyu2200 [X]Other chronic sinusitis 
Hyu2500 [X]Other chronic diseases of tonsils and adenoids 
Hyu2800 [X]Other abscess of pharynx 
Hyu2900 [X]Other diseases of pharynx 
Hyu2A00 [X]Other specified diseases of upper respiratory tract 
R041.00 [D]Throat pain 
R041.11 [D]Throat discomfort 
Appendix 4: Read code list for peritonsillar abscess 
Code Description 
 
 2DB5.00 O/E - tonsils - quinsy present 
2DB5.11 O/E - quinsy present 
7423200 Incision of retropharyngeal abscess 
7426100 Drainage of retropharyngeal abscess 
7531100 Drainage of peritonsillar abscess 
7531111 Drainage of quinsy 
H15..00 Peritonsillar abscess - quinsy 
H15..11 Quinsy 
H1y2200 Parapharyngeal abscess 
H1y2300 Retropharyngeal abscess 
Appendix 5: Read code list for obstructive sleep apnoea  
Code Description 
8724.00 CPAP - Continuous positive airways pressure 
8725.00 Bi-level positive airways pressure therapy 
8A43.00 Apnoea alarm monitoring 
Fy03.00 Sleep apnoea 
Fy03.11 Obstructive sleep apnoea 
Fy04.00 Sleep-related respiratory failure 
H5B..00 Sleep apnoea 
H5B0.00 Obstructive sleep apnoea 
Q31y000 Perinatal apnoeic spells NOS 
Q31y600 Apnoea of newborn 
Q31y611 Neonatal apnoeic attack 
Qyu3800 [X]Other apnoea of newborn 
R005100 [D]Insomnia with sleep apnoea 
R005300 [D]Hypersomnia with sleep apnoea 
R005311 [D]Sleep apnoea syndrome 
R005312 [D]Syndrome sleep apnoea 
R060200 [D]Orthopnoea 
R060400 [D]Apnoea 
Z6M..00 Positive pressure therapy 
Z6M1.00 Continuous positive airways pressure 
Z6M1.11 CPAP - Continuous positive airways pressure 
Z6M1.12 Continuous positive airways pressure therapy 
Z6M1.13 CPAP - Continuous positive airways pressure therapy 
Z6M1100 Intermittent CPAP 
Z6M1200 Continuous CPAP 
Z6M1300 Periodic CPAP 
Z6M2.00 Intermittent positive pressure breathing therapy 
Z6M2.11 IPPB - Intermittent positive pressure breathing therapy 
Z6M3.11 BIPAP - Biphasic pressure airway support 
Z6M3.12 Bi-level positive airways pressure therapy 
Z6M3.13 BIPAB - Bi-level positive airways pressure therapy 
Appendix 6: Read code list for guttate and chronic plaque psoriasis 
Code Description 
M16..00 Psoriasis and similar disorders 
M160.00 Psoriatic arthropathy 
 
 Code Description 
M160.11 Psoriatic arthritis 
M160000 Psoriasis spondylitica 
M160100 Distal interphalangeal psoriatic arthropathy 
M160200 Arthritis mutilans 
M160z00 Psoriatic arthropathy NOS 
M161.00 Other psoriasis 
M161000 Psoriasis unspecified 
M161100 Psoriasis annularis 
M161200 Psoriasis circinata 
M161300 Psoriasis diffusa 
M161400 Psoriasis discoidea 
M161500 Psoriasis geographica 
M161600 Guttate psoriasis 
M161700 Psoriasis gyrata 
M161800 Psoriasis inveterata 
M161900 Psoriasis ostracea 
M161A00 Psoriasis palmaris 
M161B00 Psoriasis plantaris 
M161C00 Psoriasis punctata 
M161D00 Pustular psoriasis 
M161E00 Psoriasis universalis 
M161F00 Psoriasis vulgaris 
M161F11 Chronic large plaque psoriasis 
M161H00 Erythrodermic psoriasis 
M161J00 Flexural psoriasis 
M161z00 Psoriasis NOS 
M166.00 Palmoplantar pustular psoriasis 
M16y.00 Other psoriasis and similar disorders 
M16y000 Scalp psoriasis 
M16z.00 Psoriasis and similar disorders NOS 
Appendix 7: Read code list for glomerulonephritis 
Code Description 
K00..00 Acute glomerulonephritis 
K00..11 Acute nephritis 
K00..12 Bright's disease 
K00..13 AGN - Acute glomerulonephritis 
K000.00 Acute proliferative glomerulonephritis 
K000000 Shunt nephritis 
K000100 Crescentic glomerulonephritis 
K000111 CGN - Crescentic glomerulonephritis 
K001.00 Acute nephritis with lesions of necrotising glomerulitis 
K00y.00 Other acute glomerulonephritis 
K00y000 Acute glomerulonephritis in diseases EC 
 
 Code Description 
K00y100 Acute exudative nephritis 
K00y200 Acute focal nephritis 
K00y300 Acute diffuse nephritis 
K00y400 Acute radiation nephritis 
K00yz00 Other acute glomerulonephritis NOS 
K00z.00 Acute glomerulonephritis NOS 
K01..00 Nephrotic syndrome 
K010.00 Nephrotic syndrome with proliferative glomerulonephritis 
K011.00 Nephrotic syndrome with membranous glomerulonephritis 
K012.00 Nephrotic syndrome+membranoproliferative glomerulonephritis 
K013.00 Nephrotic syndrome with minimal change glomerulonephritis 
K013.11 Lipoid nephrosis 
K013.12 Steroid sensitive nephrotic syndrome 
K014.00 Nephrotic syndrome, minor glomerular abnormality 
K015.00 Nephrotic syndrome, focal and segmental glomerular lesions 
K016.00 Nephrotic syndrome, diffuse membranous glomerulonephritis 
K017.00 Nephrotic syn difus mesangial prolifertiv glomerulonephritis 
K018.00 Nephrotic syn,difus endocapilary proliftv glomerulonephritis 
K019.00 Nephrotic syn,diffuse mesangiocapillary glomerulonephritis 
K01A.00 Nephrotic syndrome, dense deposit disease 
K01B.00 Nephrotic syndrome, diffuse crescentic glomerulonephritis 
K01w.00 Congenital nephrotic syndrome 
K01w000 Finnish nephrosis syndrome 
K01w011 Microcystic type congenital nephrotic syndrome 
K01w012 Congenital Finnish nephrosis 
K01w100 Drash syndrome 
K01w111 Nephrotic syndrome with pseudohermaphroditism 
K01w112 Wilms' tumor + nephrotic syndrome + pseudohermaphroditism 
K01w200 Congenital nephrotic syndrome with focal glomerulosclerosis 
K01wz00 Congenital nephrotic syndrome NOS 
K01x.00 Nephrotic syndrome in diseases EC 
K01x000 Nephrotic syndrome in amyloidosis 
K01x100 Nephrotic syndrome in diabetes mellitus 
K01x111 Kimmelstiel - Wilson disease 
K01x200 Nephrotic syndrome in malaria 
K01x300 Nephrotic syndrome in polyarteritis nodosa 
K01x400 Nephrotic syndrome in systemic lupus erythematosus 
K01x411 Lupus nephritis 
K01xz00 Nephrotic syndrome in diseases EC NOS 
K01y.00 Nephrotic syndrome with other pathological kidney lesions 
K01z.00 Nephrotic syndrome NOS 
K0A..00 Glomerular disease 
K0A0.00 Acute nephritic syndrome 
 
 Code Description 
K0A0000 Acute nephritic syndrome, minor glomerular abnormality 
K0A0100 Acute nephritic syndrome, focal+segmental glomerular lesions 
K0A0200 Acute nephritic syn, diffuse membranous glomerulonephritis 
K0A0300 Acut neph syn, diffuse mesangial prolifrative glomnephritis 
K0A0400 Ac neph syn difus endocaplry prolifrative glomerulonephritis 
K0A0500 Acute neph syn, diffuse mesangiocapillary glomerulonephritis 
K0A0600 Acute nephritic syndrome, dense deposit disease 
K0A0700 Acute nephrotic syndrm diffuse crescentic glomerulonephritis 
K0A1.00 Rapidly progressive nephritic syndrome 
K0A1000 Rapid progres neph syndrome, minor glomerular abnormality 
K0A1100 Rapid progres nephritic syn focal+segmental glomerulr lesion 
K0A1200 Rapid progres neph syn diffuse membranous glomerulonephritis 
K0A1300 Rpd prog neph syn df mesangial prolifratv glomerulonephritis 
K0A1400 Rapid progres neph syn df endocapilary prolifv glomnephritis 
K0A1500 Rapid prog neph syn df mesangiocapillary glomerulonephritis 
K0A1600 Rapid progressive nephritic syndrome, dense deposit disease 
K0A1700 Rapid progres nephritic syn df crescentic glomerulonephritis 
K0A2.00 Recurrent and persistent haematuria 
K0A2000 Recurrent+persistnt haematuria minor glomerular abnormality 
K0A2100 Recur+persist haematuria, focal+segmental glomerular lesions 
K0A2200 Recur+persist haematuria difus membranous glomerulonephritis 
K0A2300 Recur+persist haemuria df mesangial prolif glomerulnephritis 
K0A2400 Recur+persist haemuria df endocaplry prolifrtv glomeruloneph 
K0A2500 Recur+persist hmuria df mesangiocapilary glomerulonephritis 
K0A2600 Recurrent and persistent haematuria, dense deposit disease 
K0A2700 Recur+persist haematuria difus crescentic glomerulonephritis 
K0A2800 IgA nephropathy 
K0A3.00 Chronic nephritic syndrome 
K0A3000 Chronic nephritic syndrome, minor glomerular abnormality 
K0A3100 Chronic nephritic syndrm focal+segmental glomerular lesions 
K0A3200 Chron nephritic syndrom difuse membranous glomerulonephritis 
K0A3300 Chron neph syn difus mesangial prolifrtiv glomerulonephritis 
K0A3400 Chron neph syn difuse endocap prolifrativ glomerulonephritis 
K0A3500 Chronic neph syn difus mesangiocapillary glomerulonephritis 
K0A3600 Chronic nephritic syndrome, dense deposit disease 
K0A3700 Chronic nephritic syn diffuse crescentic glomerulonephritis 
K0A4.00 Isolated proteinuria with specified morphological lesion 
K0A4000 Isolatd proteinur specfd morphlgcl lesion min glom abnrm 
K0A4100 Isolatd proteinur/specifd morphlgcl les foc+seg glom lesn 
K0A4200 Isolatd proteinur/specfd morphlgcl les df membrn glomneph 
K0A4300 Isoltd prteinur/spcfd morph lesn df mesngl prolf glomneph 
K0A4400 Isolt prteinur/spcfd morph les df endocap prolif glomneph 
K0A4500 Isoltd prteinur+specfd morph les df mesangiocap glomnephr 
 
 Code Description 
K0A4600 Isolatd proteinur spcfd morph lesion dense deposit diseas 
K0A4700 Isol proteinur specfd morph lesion df crescentic glomneph 
K0A4W00 Isolated proteinuria, with unspecified morpholog changes 
K0A4X00 Isolated proteinuria, with oth specif morpholog changes 
K0A5.00 Hereditary nephropathy not elsewhere classified 
K0A5000 Hereditary nephropathy NEC, minor glomerular abnormality 
K0A5100 Hereditary nephropathy NEC,focal+segmnt glomerular lesion 
K0A5200 Hereditry nephropathy NEC,difus membran glomerulnephritis 
K0A5300 Heredtry nephrpthy NEC difus mesangial prolif glomnephrit 
K0A5400 Heredtry nephrpthy NEC difus endocapil prolif glomnephrit 
K0A5500 [X]Heredtry nephrpthy NEC difus mesangiocapilry glomneph 
K0A5600 Hereditary nephropathy, NEC, dense deposit disease 
K0A5700 Hereditary nephropathy,NEC,difus crescentic glomnephritis 
K0A5X00 Hereditary nephropathy, unspecif morphological changes 
K0A6.00 Glomerular disorders in neoplastic diseases 
K0A7.00 Glom disordr in blood diseas+disordr invlvg imun mechansm 
K0A8.00 Rapidly progressive glomerulonephritis 
K0A9.00 Cytomegalovirus-induced glomerulonephritis 
Kyu0.00 [X]Glomerular diseases 
Kyu0000 [X]Glomerular disorders in infectious+parasitic diseases CE 
Kyu0100 [X]Glomerular disorders in neoplastic diseases CE 
Kyu0200 [X]Glomerulr disordrs/bld dis+disordr inv immune mechansm CE 
Kyu0300 [X]Glomerular disorders in diabetes mellitus 
Kyu0400 [X]Glomerulr disordr/oth endocrine,nutritnl+metabolic dis CE 
Kyu0500 [X]Glomerular disordrs/systemic disordrs/connectiv tissue CE 
Kyu0600 [X]Glomerular disorders in other diseases CE 
Kyu0700 [X]Rapidly progressive nephritic syndrome, other 
Kyu0800 [X]Unspecif nephritic syndr, minor glomerular abnormality 
Kyu0900 [X]Unsp nephrit synd, diff mesang prolif glomerulonephritis 
Kyu0A00 [X]Unsp nephrit synd, diff endocap prolif glomerulonephritis 
Kyu0B00 [X]Unspecified nephritic syndrome, dense deposit disease 
Kyu0C00 [X]Unspecif nephr synd, diff concentric glomerulonephritis 
Kyu0D00 [X]Isolated proteinuria, with oth specif morpholog changes 
Kyu0E00 [X]Isolated proteinuria, with unspecified morpholog changes 
Kyu0F00 [X]Hereditary nephropathy, unspecif morphological changes 
SP08b00 De novo glomerulonephritis 
Appendix 8: Read code list for other sleep disordered breathing 
Code Description 
1C7..00 Snoring symptoms 
1C72.00 Snores 
1C7Z.00 Snoring symptom NOS 
2DB..11 O/E - tonsils enlarged 
2DB3.00 O/E - tonsils mod. enlarged 
 
 2DB4.00 O/E - tonsils grossly enlarged 
3148.00 Sleep studies 
38Da.00 Berlin questionnaire for sleep apnoea 
7065800 Sleep studies 
7065A00 Sleep studies NEC 
7527800 Injection snoreplasty 
7527900 Radiofrequency somnoplasty 
7P1B000 Polysomnography 
9b9Y.00 Sleep studies - specialty 
H141.00 Tonsil and/or adenoid hypertrophy 
H141.11 Adenoid hypertrophy 
H141.12 Enlargement of tonsil or adenoid 
H141000 Hypertrophy of tonsils and adenoids 
H141100 Hypertrophy of tonsils alone 
H141200 Hypertrophy of adenoids alone 
H141z00 Hypertrophy of tonsils and adenoids NOS 
H1yz200 Upper airway resistance syndrome 
R060B00 [D]Snoring 
Appendix 9: Read code list for tonsillectomy and adenotonsillectomy 
Code Description 
7530.00 Excision of tonsil 
7530.11 Tonsillectomy 
7530000 Dissection tonsillectomy 
7530100 Guillotine tonsillectomy 
7530200 Bilateral laser tonsillectomy 
7530300 Other bilateral tonsillectomy 
7530400 Excision of remnant of tonsil 
7530500 Excision of lingual tonsil 
7530600 Tonsillectomy and adenoidectomy 
7530700 Other unilateral tonsillectomy 
7530800 Dissection tonsillectomy and adenoidectomy 
7530900 Guillotine tonsillectomy and adenoidectomy 
7530A00 Bilateral dissection tonsillectomy 
7530B00 Bilateral guillotine tonsillectomy 
7530C00 Coblation tonsillectomy 
7530D00 Bilateral coblation tonsillectomy 
7530y00 Other specified excision of tonsil 
7530z00 Excision of tonsil NOS 
 
 
